Skip to main content

Table 1 Characteristics of studies included in the systematic review of gastric cancer incidence in patients with gastric atrophy

From: Adenocarcinoma risk in gastric atrophy and intestinal metaplasia: a systematic review

First author (Year) [reference] Country Study design Indication(s) for endoscopy Study follow up period Outcome source Number of patients in cohort Male (%) Mean age (years) Follow-up (years) [mean/median] HP* positive (%)
González (2016) [38] Spain Retrospective cohort NR* 1995–2013 Pathology records, clinical records, endoscopy 156 46 49 12 (mean) 80
Inoue (2000) [10] Japan Prospective cohort NR* 1985–1999 Hospital records, Cancer registry, mail survey 4397 48 50 10 (mean) NR*
Lahner (2015) [11] Italy Prospective cohort Surveillance programme 1992–2009 Endoscopy 200 33 55 7.5 (median) NR*
Siurala (1974) [35] Finland Prospective cohort NR* 1950–1973 Endoscopy 116 NR* 64 21 (mean) NR*
Song (2015) [36] Sweden Retrospective cohort Dyspepsia 1979–2011 Endoscopy, Cancer registry, ONS* 14,285 55 60 10.1 (mean) NR*
Takata (2007) [25] Japan Prospective cohort NR* 1991–2001 NR* 101 58 56 5.2 (mean) NR*
Tatsuta (1993) [8] Japan Retrospective cohort NR* 1968–1976 Cancer registry, pathology database 194 80 NR* 19 (mean) 100
Vannella (2010) [17] Italy Prospective cohort NR* 1992–2008 Endoscopy 300 32 54 4.3 (median) 6
  1. *NR Information not available, HP Helicobacter pylori, ONS Office for National Statistics